The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2024

Filed:

Jun. 11, 2020
Applicant:

Helixbind, Inc., Boxborough, MA (US);

Inventors:

Alon Singer, Concord, MA (US);

Ranjit Prakash, Northborough, MA (US);

Assignee:

HelixBind, Inc., Boxborough, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01L 3/00 (2006.01); B01D 63/08 (2006.01); B01D 69/02 (2006.01); B01D 71/34 (2006.01); B01L 7/00 (2006.01); C12Q 1/686 (2018.01);
U.S. Cl.
CPC ...
B01L 3/502 (2013.01); B01D 71/34 (2013.01); B01L 3/5027 (2013.01); C12Q 1/686 (2013.01); B01D 63/088 (2013.01); B01D 69/02 (2013.01); B01D 2325/20 (2013.01); B01D 2325/38 (2013.01); B01L 7/52 (2013.01); B01L 2200/0673 (2013.01); B01L 2200/0684 (2013.01); B01L 2200/0689 (2013.01); B01L 2200/16 (2013.01); B01L 2300/0681 (2013.01); B01L 2300/0816 (2013.01); B01L 2300/0867 (2013.01); B01L 2300/087 (2013.01); B01L 2300/166 (2013.01); B01L 2300/1827 (2013.01); B01L 2400/0487 (2013.01); B01L 2400/049 (2013.01); B01L 2400/06 (2013.01);
Abstract

Fluidic devices and related methods are generally provided. The fluidic devices described herein may be useful, for example, for diagnostic purposes (e.g., detection of the presence of one or more disease causing bacteria in a patient sample). Unlike certain existing fluidic devices for diagnostic purposes, the fluidic devices and methods described herein may be useful for detecting the presence of numerous disease causing bacteria in a patient sample substantially simultaneously (e.g., in parallel). In some embodiments, the fluidic devices and methods described herein provide highly sensitive detection of microbes in relatively large fluidic samples (e.g., between 0.5 mL and about 5 mL), as compared to certain existing fluidic detection (e.g., microfluidic) devices and methods. In an exemplary embodiment, increased detection sensitivity of microbial pathogens present in a patient sample (e.g., blood) is performed by selectively removing human nucleic acid prior to sensitive detection of microbial infection. In some embodiments, the fluidic device allows for the identification of microbial pathogens directly from unprocessed blood without having to conduct blood culturing processes.


Find Patent Forward Citations

Loading…